Take
TAKE NSE
Take
HealthcareNSE: TAKE BSE: 532890 Healthcare Services
Key Fundamentals
MicrocapHealthcare TechnologyHealthcareMarket Cap
₹261 Cr
Volatility
Moderate
P/E Ratio
19.5
EBITDA
₹-1.91 Cr
Return on Equity
3.6%
Debt to Equity
0
Book Value
₹2.1
52W High
₹50.14
52W Low
₹10.09
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Company is almost debt free.
Weaknesses
7- Stock is trading at 8.40 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -41.2% over past five years.
- Tax rate seems low
- Company has a low return on equity of -47.0% over last 3 years.
- Earnings include an other income of Rs.14.9 Cr.
- Working capital days have increased from -2,718 days to 123 days
Growth Rate
Revenue Growth
431% higher than
3Y
Net Income Growth
—
Cash Flow Change
-276% lower than
3Y
ROE
-99.52% lower than
3Y
ROCE
-99.77% higher than
3Y
EBITDA Margin (Avg.)
-111% lower than
3Y
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.55 | 0.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 54.19 | 30.37 |
| Expenses | 5.5 | 1.5 | 1.98 | 15.76 | 2.22 | 0.9 | 2.89 | 1.15 | 0.44 | 0.3 | 0.35 | 55.01 | 30.64 |
| Operating Profit | -1.95 | -1.45 | -1.98 | -15.76 | -2.22 | -0.9 | -2.89 | -1.15 | -0.44 | -0.3 | -0.35 | -0.82 | -0.27 |
| OPM % | -54.93% | -2900% | — | — | — | — | — | — | — | — | — | -1.51% | -0.89% |
| Other Income | -2.25 | 0.41 | 4.07 | -93.7 | -0.97 | -0.23 | 51.31 | -3.48 | -0.29 | 6.92 | 1.46 | 5.18 | 1.33 |
| Interest | 0.64 | 0.56 | 0.54 | 0.54 | 0.49 | 0.5 | 0.73 | 0.24 | 0.18 | 0.17 | 0 | 0 | 0 |
| Depreciation | 0.3 | 0.3 | 0.11 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 |
| PBT | -5.14 | -1.9 | 1.44 | -110 | -3.69 | -1.64 | 47.68 | -4.88 | -0.91 | 6.45 | 1.11 | 4.36 | 1.06 |
| Tax % | 3.5% | -18.42% | 248.61% | 0.55% | 1.63% | -3.66% | 0% | 0% | 0% | 2.48% | 0% | 0% | 0% |
| Net Profit | -5.32 | -1.55 | -2.14 | -111 | -3.75 | -1.58 | 47.68 | -4.88 | -0.91 | 6.29 | 1.11 | 4.36 | 1.06 |
| EPS in Rs | -0.36 | -0.1 | -0.14 | -7.48 | -0.25 | -0.11 | 3.22 | -0.33 | -0.06 | 0.43 | 0.08 | 0.29 | 0.07 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 730 | 1,030 | 1,345 | 1,587 | 2,039 | 2,213 | 774 | 655 | 189 | 4 | 0 | 54 | 85 |
| Expenses | 581 | 817 | 1,082 | 1,281 | 1,655 | 2,044 | 847 | 648 | 208 | 24 | 7 | 56 | 86 |
| Operating Profit | 149 | 213 | 262 | 307 | 384 | 169 | -73 | 7 | -19 | -20 | -7 | -2 | -2 |
| OPM % | 20% | 21% | 20% | 19% | 19% | 8% | -9% | 1.1% | -10% | -569% | — | -3.5% | -2.1% |
| Other Income | 8 | 21 | 13 | 6 | 11 | 26 | -211 | -677 | -56 | -92 | 47 | 13 | 15 |
| Interest | 13 | 15 | 23 | 21 | 25 | 41 | 37 | 29 | 7 | 2 | 2 | 0 | 0 |
| Depreciation | 60 | 74 | 87 | 104 | 154 | 167 | 115 | 80 | 17 | 1 | 0 | 0 | 0 |
| PBT | 85 | 145 | 165 | 188 | 216 | -13 | -437 | -779 | -99 | -116 | 37 | 11 | 13 |
| Tax % | 6% | 14% | 11% | 15% | 17% | -15% | 3% | 0% | 2% | 3% | 0% | 1% | — |
| Net Profit | 80 | 125 | 146 | 160 | 178 | -11 | -450 | -782 | -100 | -120 | 37 | 11 | 13 |
| EPS in Rs | 5.71 | 9.78 | 10.74 | 10.85 | 11.99 | -0.84 | -30.56 | -52.88 | -6.78 | -8.09 | 2.53 | 0.73 | 0.87 |
| Div. Payout % | 17% | 10% | 9% | 15% | 8% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 12 | 12 | 13 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 |
| Reserves | 512 | 619 | 898 | 1,314 | 1,504 | 1,561 | 1,110 | 166 | 94 | -24 | 6 | 16 |
| Borrowings | 209 | 336 | 237 | 323 | 474 | 553 | 514 | 59 | 46 | 37 | 0 | 0 |
| Other Liabilities | 189 | 246 | 221 | 189 | 339 | 336 | 187 | 984 | 69 | 60 | 16 | 5 |
| Total Liabilities | 922 | 1,214 | 1,369 | 1,840 | 2,331 | 2,465 | 1,826 | 1,223 | 224 | 88 | 36 | 36 |
| Fixed Assets | 359 | 543 | 554 | 589 | 1,091 | 1,234 | 934 | 101 | 73 | 30 | 0 | 0 |
| CWIP | 17 | 3 | 21 | 42 | 41 | 1 | 0 | 3 | 11 | 0 | 0 | 0 |
| Investments | 6 | 21 | 10 | 59 | 10 | 18 | 7 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 541 | 647 | 785 | 1,150 | 1,188 | 1,213 | 885 | 1,119 | 140 | 58 | 36 | 36 |
| Total Assets | 922 | 1,214 | 1,369 | 1,840 | 2,331 | 2,465 | 1,826 | 1,223 | 224 | 88 | 36 | 36 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 74 | 151 | 56 | 121 | 104 | 211 | 135 | 30 | 20 | 9 | -16 | -4 |
| Investing | -14 | -292 | -130 | -179 | -474 | -233 | -57 | 15 | -3 | -7 | 22 | 2 |
| Financing | -11 | 111 | 56 | 302 | 100 | 21 | -84 | -55 | -36 | -12 | -3 | -1 |
| Net Cash Flow | 49 | -30 | -18 | 243 | -270 | -2 | -6 | -10 | -18 | -10 | 3 | -3 |
| Free Cash Flow | 46 | 35 | -30 | 39 | -23 | 54 | 133 | -2 | -12 | 2 | -16 | -4 |
| CFO/OP | 52 | 76 | 26 | 44 | 30 | 156 | -212 | 704 | -114 | -43 | 217 | 208 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 120 | 107 | 118 | 108 | 94 | 116 | 205 | 45 | 58 | 715 | — | 1 |
| Inventory Days | — | — | — | — | — | — | — | — | — | — | — | 0 |
| Cash Conversion Cycle | 120 | 107 | 118 | 108 | 94 | 116 | 205 | 45 | 58 | 715 | — | 1 |
| Working Capital Days | 42 | 19 | 90 | 85 | 67 | 80 | 140 | 28 | -42 | -5,559 | — | 123 |
| ROCE % | 13% | 16% | 17% | 15% | 13% | 1% | -9% | -6% | -14% | -22% | 11% | 19% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Take insights
36 extracted metrics + investor summaries across FY15–FY26.
Documents
1
Intimation Of Cut-Off Date For E-Voting For The 25Th Annual General Meeting
12 Sep - September 22, 2026 cut-off date fixed for 25th AGM e-voting; AGM on September 29, 2026. 12 Sep - September 22, 2026 cut-off date fixed for 25th AGM e-voting; AGM on September 29, 2026.
2
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
30 Apr - TAKE Solutions says it is not a Large Corporate as on March 31, 2026. 30 Apr - TAKE Solutions says it is not a Large Corporate as on March 31, 2026.
3
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
30 Apr - TAKE Solutions says it is not a Large Corporate as on March 31, 2026. 30 Apr - TAKE Solutions says it is not a Large Corporate as on March 31, 2026.
4
Announcement under Regulation 30 (LODR)-Press Release / Media Release
17 Apr - Take Solutions plans entry into India’s longevity and anti-ageing market with nutraceuticals and digital wellness products. 17 Apr - Take Solutions plans entry into India’s longevity and anti-ageing market with nutraceuticals and digital wellness products.
5
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
13 Apr - Certificate pursuant to Regulation 74 (5) of SEBI (Depositories and Participants) Regulation 2018. 13 Apr - Certificate pursuant to Regulation 74 (5) of SEBI (Depositories and Participants) Regulation 2018.
2
Notice Of The 25Th Annual General Meeting For FY 2025-26 On Tuesday September 29 2026 At 12:00 P.M. 7 Sept 2026
Intimation
Frequently Asked Questions about Take
What does Take Ltd do?
Incorporated in 2000, TAKE Solutions Ltd is in the business of Life Sciences and Support Services[1]
Where is Take Ltd (TAKE) listed?
Take Ltd trades as TAKE on the NSE and under code 532890 on the BSE.
Which sector does Take Ltd belong to?
Take Ltd is classified under the Healthcare sector, in the Healthcare Services industry.
What is the market capitalisation of Take Ltd?
Take Ltd has a market capitalisation of ₹260.51 Cr, which places it in the Small Cap band.
What is the PE ratio of Take Ltd?
Take Ltd trades at a PE ratio of 19.50, against a book value of ₹2.1 per share.
What is the 52-week high and low of Take Ltd?
Over the last 52 weeks Take Ltd has traded between ₹10.09 and ₹50.14.
What is the Return on Equity (ROE) of Take Ltd?
Take Ltd reported a return on equity of 3.60%. Its debt-to-equity ratio is 0.00.
Company Information
Incorporated in 2000, TAKE Solutions Ltd is in the business of Life Sciences and Support Services[1]
Website takesolutions.com
CEO Ms. Sonia Bhimrajka
Employees 2
Listed 2007-08-27
Face Value ₹ 1
Issued Size 14,79,34,000
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/TAKE.md for Take Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.